|Articles|March 1, 2012
Summary and Closing of Discussion
Dr. Chernew summarizes key points of the discussion and asks members to add any additional information.
Advertisement
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Early Treatment Succeeds in CRC With Next Generation KRAS Inhibitor Calderasib Plus Cetuximab Combo
2
Tec-Dara Shows MRD-Negative, PFS Benefit in High-Risk Myeloma, But Longer Follow-Up Needed: Rahul Banerjee, MD
3
Real-World Data Show MASH Progresses Faster Than Trials Suggest
4
Adam Kittai, MD, on Sequencing, Cost, and the Road to CLL Cure
5